Abstract Introduction: Hyperandrogenism affects approximately 10–20% of women of
reproductive age. Hyperandrogenic skin symptoms such as hirsutism, acne, seborrhea and …

Twenty-four hirsute women were treated with an inversal sequential scheme of cyproterone
acetate, 50 mg/d by oral route from the 1st to the 15th day of the menstrual cycle, along with …

Objectives: We reviewed the mechanism of androgen actions and the established and
experimental uses of antiandrogens in women. Methods: Relevant studies were identified …

Objective Effectiveness of 2-year treatment of hirsutism with low estrogen oral contraceptives
(OCs) containing nonandrogenic or antiandrogenic progestogen. Evaluation of changes in …

Objective: This study was undertaken to compare the clinical efficacy of second-versus third-
generation oral contraceptives in the treatment of acne. Study Design: Thirty-four women …

Oral contraceptives (OCs) can reduce acne by lowering the production of adrenal and
ovarian androgens, by inhibiting 5-alpha-reductase, which in turn, reduces the levels of …

Background Cyproterone acetate is a potent antiandrogen with strong progestational
activity. In combination with ethinyloestradiol, it has been shown to be of clinical benefit to …

This study shows the effect of a 1 year treatment with an estradiol valerate/dienogest pill in
36 women suffering from polycystic ovaries and mild or moderate acne. At beginning of the …

Although polycystic ovary syndrome (PCOS) is a multifaceted condition, the symptoms of
hyperandrogenism frequently bring the patient to medical attention. These include hirsutism …

BACKGROUND In recent years, several new oral contraceptives have become available. In
some ways, they represent an evolution in terms of individualization and compliance on the …